We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 837 results
  1. METTL3 promotes osteoblast ribosome biogenesis and alleviates periodontitis

    Background

    Periodontitis is a highly prevalent oral disease characterized by bacterium-induced periodontal inflammation and alveolar bone destruction....

    Yiwen Zhang, Yi** Kong, ... Qiong Xu in Clinical Epigenetics
    Article Open access 24 January 2024
  2. Inhibition of METTL3 in macrophages provides protection against intestinal inflammation

    Inflammatory bowel disease (IBD) is prevalent, and no satisfactory therapeutic options are available because the mechanisms underlying its...

    Huilong Yin, Zhuan Ju, ... Rui Zhang in Cellular & Molecular Immunology
    Article 22 April 2024
  3. METTL3 promotes microglial inflammation via MEF2C in spinal cord injury

    Spinal cord injury (SCI) is a significant contributor to disability in contemporary society, resulting in substantial psychological and economic...

    Dongliang Wang, Wei Qian, ... Guoyou Zou in Cell and Tissue Research
    Article 05 January 2024
  4. Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis

    Kidney fibrosis is a major mechanism underlying chronic kidney disease (CKD). N 6 -methyladenosine (m 6 A) RNA methylation is associated with organ...

    Hae Rim Jung, Jeonghwan Lee, ... Sung-Yup Cho in Experimental & Molecular Medicine
    Article Open access 01 February 2024
  5. Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma

    Methyltransferase-like 3 (METTL3) is the key subunit of methyltransferase complex responsible for catalyzing N6-methyladenosine (m 6 A) modification on...

    Qingbin Liu, **g**g Qi, ... Shulong Jiang in Cancer Cell International
    Article Open access 27 November 2023
  6. The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target

    The incidence of prostate cancer (PCa), the most prevalent malignancy, is currently at the forefront. RNA modification is a subfield of the booming...

    Xuming Zhou, Keqiang Chai, ... Guoxi Zhang in BMC Cancer
    Article Open access 02 January 2024
  7. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer

    Background

    N6-methyladenosine (m6A) methylation is the most abundant chemical posttranscriptional modification of mRNA, and it is associated with the...

    Lei Zhan, **g Zhang, ... Yun-**a Cao in Biomarker Research
    Article Open access 21 April 2023
  8. METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2

    This study aimed to investigate the roles of METTL3, a regulator of m6A, in NSCLC. RT-qPCR was applied to determine mRNA of m6A-associated genes and...

    Shu Zhao, Peng Song, ... Yi Hu in Cancer Gene Therapy
    Article 27 April 2023
  9. M2 macrophage exosomal LINC01001 promotes non-small cell lung cancer development by affecting METTL3 and glycolysis pathway

    There have been data showing that LINC01001 is highly expressed in lung cancer, but the effect of M2 macrophage exosomal LINC01001 to METTL3,...

    Li Xu, Kang Li, ... Bolin Chen in Cancer Gene Therapy
    Article 04 September 2023
  10. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway

    Liver cancer stem cells (LCSCs) contribute to tumor recurrence and cancer cell proliferation in patients with hepatocellular carcinoma (HCC)....

    **g**g Hu, Ke Chen, ... Hua Yin in Cancer Gene Therapy
    Article 29 November 2023
  11. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression

    Background

    HOTAIRM1 is revealed to facilitate the malignant progression of glioma. Vasculogenic mimicry (VM) is critically involved in glioma...

    Zhangyi Wu, Nan Wei in Journal of Translational Medicine
    Article Open access 27 November 2023
  12. The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894

    Background

    Long noncoding RNAs (lncRNAs) are significant contributors to various human malignancies. The aberrant expression of lncRNA LINC00894 has...

    **ang Zhou, Lisha Chang, ... Leitao Yu in Cancer Cell International
    Article Open access 30 January 2024
  13. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy

    Background

    Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Although most patients are initially sensitive to first-line...

    Yueqin Sun, Weitao Shen, ... Jian Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 17 March 2023
  14. METTL3 Mediates Microglial Activation and Blood–Brain Barrier Permeability in Cerebral Ischemic Stroke by Regulating NLRP3 Inflammasomes Through m6A Methylation Modification

    Cerebral ischemic stroke (CIS) is the main cause of disability. METTL3 is implicated in CIS, and we explored its specific mechanism. Middle cerebral...

    Xue Cheng, Zhetan Ren, ... Gang Wang in Neurotoxicity Research
    Article 13 February 2024
  15. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis

    Background

    The regulatory role of N6-methyladenosine (m6A) modification in the onset and progression of cancer has garnered increasing attention in...

    Peng Ouyang, Kang Li, ... Zhen Bao in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 April 2024
  16. METTL3-mediated pre-miR-665/DLX3 m6A methylation facilitates the committed differentiation of stem cells from apical papilla

    Methyltransferase-like 3 (METTL3) is a crucial element of N6-methyladenosine (m 6 A) modifications and has been extensively studied for its involvement...

    Tingjie Gu, Rong Guo, ... Zehan Li in Experimental & Molecular Medicine
    Article Open access 03 June 2024
  17. EGR1-Driven METTL3 Activation Curtails VIM-Mediated Neuron Injury in Epilepsy

    Uncovering mechanisms underlying epileptogenesis aids in preventing further epilepsy progression and to lessen seizure severity and frequency. The...

    Zhaofei Dong, Fuli Min, ... Tao Zeng in Neurochemical Research
    Article 02 June 2023
  18. METTL3 Modulates TXNIP Expression to Affect the Activation of NLRP3 Inflammasome in Hepatic Cells Under Oxygen–Glucose Deprivation/Reperfusion Injury

    Hepatic ischemia–reperfusion (I/R) injury is still a major risk factor and unsolved problem in hepatic surgery. Methyltransferase-like 3 (METTL3), an...

    Yong Zhang, Jianrui Lv, ... Zhenni Zhang in Inflammation
    Article 18 January 2024
  19. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing

    Background

    Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic...

    **aotong Wang, **g Wang, ... Guangmei Zhang in Journal of Translational Medicine
    Article Open access 23 June 2023
  20. ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer

    Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease with poor prognosis. Acetylation modifications affect a great number...

    Gong Zhang, Ruyi Huang, ... Yiyao Cui in Genes & Immunity
    Article 08 March 2023
Did you find what you were looking for? Share feedback.